Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 13 , ISSUE 6 ( November-December, 2021 ) > List of Articles

CASE SERIES

Sickle Cell Anemia Complicating Pregnancy in Coronavirus Disease Era: Managing Two Maladies

Kaustav Kar, Subhra Samantaroy, Jyochnamayi Panda, Pramila Jena

Keywords : Coronavirus, Coronavirus disease-2019, Gestational, Pregnancy, Sickle cell anemia, Sickle cell disease

Citation Information : Kar K, Samantaroy S, Panda J, Jena P. Sickle Cell Anemia Complicating Pregnancy in Coronavirus Disease Era: Managing Two Maladies. J South Asian Feder Obs Gynae 2021; 13 (6):441-442.

DOI: 10.5005/jp-journals-10006-1983

License: CC BY-NC 4.0

Published Online: 04-03-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Aim and objective: The aim and objective of this case series is to enlighten the effect of coronavirus disease-2019 (COVID-19) infection in pregnant patients with sickle cell disease. Background: The novel coronavirus or COVID-19 infection continues to challenge healthcare providers with the countless number of waves ravaging across the globe, questioning some of the intransigent beliefs regarding behavior of viruses. COVID-19 creates a milieu of thrombotic state which is of particular importance in cases who are already at risk like those with sickle cell disease especially that in a pregnant population. Thus, we share here three case reports of sickle cell disease patients who came out COVID-positive during pregnancy. Case description: We discuss three cases of pregnant patients with history of sickle cell disease who were COVID-19-positive and were treated on an in-patient basis. All of them presented with symptoms of crisis, but all three cases responded well to therapy and were subsequently discharged in a stable condition. Conclusion: Our experience with these three cases was that all of them presented with symptoms of crisis, however, were these caused by the presence of the coexisting COVID-19 infection is a subject to further research. Clinical significance: In the era of pandemic, especially in case of a new contagion, it is of immense importance to document and share as much as possible regarding the behavior of the virus in patients with different comorbid conditions. While there are much literature available of the clinical picture of COVID-19 in case of the more common comorbidities like diabetes mellitus and hypertension, there is a significant lack in availability of proper literary guidance in case of some rarer but significant conditions like hemoglobinopathies. We hope our case series creates a paradigm for future research on the role of COVID-19 in more uncommon comorbidities.


HTML PDF Share
  1. Vasava B, Chudasama RK, Godara NR, et al. Sickle cell disease status among school adolescents and their tribal community in South Gujarat. Online J Health Allied Scs. 2009;8(2):4. Available from: https://www.ojhas.org/issue30/2009-2-4.htm
  2. Abou-Ismail MY, Diamond A, Kapoor S, et al. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management [published correction appears in Thromb Res. 2020 Nov 26;:]. Thromb Res 2020;194:101–115. DOI:10.1016/j.thromres.2020.06.029.
  3. Villers MS, Jamison MG, De Castro LM, et al. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol 2008;199(2):125.e1–125.e1255. DOI: 10.1016/j.ajog.2008.04.016.
  4. Hussain FA, Njoku FU, Saraf SL, et al. COVID-19 infection in patients with sickle cell disease. Br J Haematol 2020;189(5):851–852. DOI: 10.1111/bjh.16734.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.